Jubilant Pharma redeems Senior Notes aggregating USD 200 mn
Jubilant Pharmova announced that its wholly owned subsidiary, Jubilant Pharma, Singapore has on 18 August 2022 redeemed the principal amount of US$200,000,000 6% Senior Notes Due in 2024 at a redemption price of 103% together with the accrued interest.
After the said redemption, the Notes have been paid in full and no amount remains outstanding under the Notes. Further, Jubilant Pharma does not have any other securities listed on SGX.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Buzzing :
Greece in crisisTravel & Budget & EuropeSaaS $ Email MarketingHarnautBlacklisting Policy 2Question Paper Leak 2A big moment for small armsAI in Financial Markets: How Technology is Changing Investing'India's size and diversity make it a powerful innovation engine'Datanomics: Housing, gold loans drive household debt to a decade highSamrat ChoudharyEl Nino
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 19 2022 | 2:39 PM IST